Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials

SD Navaneethan, SC Palmer, JC Craig… - American journal of …, 2009 - Elsevier
BACKGROUND: Phosphate binders are widely used to control serum phosphorus levels in
patients with chronic kidney disease (CKD). We analyzed the effects of phosphate binders …

The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis

SA Jamal, D Fitchett, CE Lok… - Nephrology Dialysis …, 2009 - academic.oup.com
Background. The effects of calcium compared with non-calcium-based phosphate binders
on mortality, cardiovascular events and vascular calcification in patients with chronic kidney …

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta …

SA Jamal, B Vandermeer, P Raggi, DC Mendelssohn… - The Lancet, 2013 - thelancet.com
Background Phosphate binders (calcium-based and calcium-free) are recommended to
lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney …

Effects of phosphate binders in moderate CKD

GA Block, DC Wheeler, MS Persky… - Journal of the …, 2012 - journals.lww.com
Some propose using phosphate binders in the CKD population given the association
between higher levels of phosphorus and mortality, but their safety and efficacy in this …

[HTML][HTML] Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trials

SC Palmer, S Gardner, M Tonelli, D Mavridis… - American Journal of …, 2016 - Elsevier
Background Guidelines preferentially recommend noncalcium phosphate binders in adults
with chronic kidney disease (CKD). We compare and rank phosphate-binder strategies for …

Outcomes associated with phosphorus binders in men with non–dialysis-dependent CKD

CP Kovesdy, O Kuchmak, JL Lu… - American journal of kidney …, 2010 - Elsevier
BACKGROUND:: Phosphorus binders are used to treat hyperphosphatemia in maintenance
dialysis patients, in whom the use of these medications has been associated with lower …

The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney …

S Habbous, S Przech, R Acedillo… - Nephrology Dialysis …, 2017 - academic.oup.com
Background. It remains unclear which phosphate binders should be preferred for
hyperphosphatemia management in chronic kidney disease (CKD). Methods. We performed …

[HTML][HTML] Comparative effectiveness of phosphate binders in patients with chronic kidney disease: a systematic review and network meta-analysis

N Sekercioglu, L Thabane, JP Díaz Martínez… - PloS one, 2016 - journals.plos.org
Background Chronic kidney disease-mineral and bone disorder (CKD-MBD) has been
linked to poor health outcomes, including diminished quality and length of life. This condition …

A review of phosphate binders in chronic kidney disease: incremental progress or just higher costs?

WLS Peter, LD Wazny, E Weinhandl, KE Cardone… - Drugs, 2017 - Springer
As kidney disease progresses, phosphorus retention also increases, and phosphate binders
are used to treat hyperphosphatemia. Clinicians prescribe phosphate binders thinking that …

Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD)

M Ruospo, SC Palmer, P Natale… - Cochrane Database …, 2018 - cochranelibrary.com
Background Phosphate binders are used to reduce positive phosphate balance and to lower
serum phosphate levels for people with chronic kidney disease (CKD) with the aim to …